Table 1 Comparison of the characteristics of survivors and non-survivors.
Survivors (n = 288) | Non-survivors (n = 43) | p value | |
|---|---|---|---|
Age (yrs) | 68.8 ± 12.7 | 77.7 ± 13.1 | <0.001* |
Male | 193(67.0%) | 24(55.8%) | 0.15 |
Hypertension | 251(87.2%) | 39(90.7%) | 0.51 |
Smoking | 141(49.0%) | 15(34.9%) | 0.09 |
Dyslipidemia | 160(55.6%) | 13(30.2%) | 0.002* |
Family history of CAD | 18(6.3%) | 0(0%) | 0.09 |
Glycemic gap, mg/dL | 58.3 ± 84.8 | 95.7 ± 119.8 | 0.01* |
Admission glucose, mg/dL | 227.6 ± 97.8 | 260.7 ± 131.5 | 0.12 |
Max. glucose during first 48 h, mg/dL | 281.5 ± 98.9 | 328.1 ± 118.8 | 0.005* |
HbA1c, % | 7.5 ± 1.7 | 7.4 ± 1.7 | 0.59 |
BNP, pg/ml | 940 ± 1045 | 1967 ± 1571 | 0.005* |
Hb, g/dL | 12.5 ± 2.7 | 11.4 ± 2.7 | 0.01* |
Cr, mg/dL | 2.8 ± 3.7 | 2.9 ± 2.8 | 0.94 |
Alb, g/dL | 3.3 ± 0.46 | 3.1 ± 0.59 | 0.10 |
Total cholesterol, mg/dL | 165.6 ± 56.5 | 136.9 ± 39.5 | 0.006* |
Triglycerol, mg/dL | 163.6 ± 202.9 | 99.6 ± 41.1 | 0.08 |
Bilirubin, mg/dL | 0.77 ± 0.8 | 1.11 ± 1.4 | 0.17 |
LDL, mg/dL | 104.1 ± 40.5 | 89.6 ± 43.6 | 0.13 |
HDL, mg/dL | 37.7 ± 11.6 | 40.1 ± 10.7 | 0.56 |
Uric acid, mg/dL | 6.5 ± 3.5 | 7.1 ± 2.4 | 0.39 |
Peak CK, U/L | 1109 ± 2073 | 809 ± 1133 | 0.36 |
Peak troponin-I, ng/mL | 24.1 ± 33.0 | 28.3 ± 37.2 | 0.45 |
STEMI | 71(24.7%) | 6(14.0%) | 0.17 |
Killip class | <0.001* | ||
I | 92(31.9%) | 0(0%) | |
II | 95(33.0%) | 4(9.3%) | |
III | 85(29.5%) | 12(27.9%) | |
IV | 16(5.6%) | 27(62.8%) | |
Number of Diseased vessels | 0.24 | ||
Single-vessel | 26(10.9%) | 2(6.9%) | |
Double-vessel | 61(25.5%) | 4(13.8%) | |
Triple-vessel | 152(63.6%) | 23(79.3%) | |
GRACE scores | 171.4 ± 1.2 | 224.1 ± 1.2 | <0.001* |
Hospital stay (days) | 13.2 ± 17.8 | 25.0 ± 27.3 | 0.008* |
